TickrTrends TMDX fair value analysis

A Look at TransMedics Group Inc (TMDX) After 4.4% Gain -- GF Value $160.62 vs Price $74.75

gurufocus.com · 2026-10-21

On October 20, 2026, TransMedics Group Inc (TMDX) shares rose 4.4% to a current price of $74.75. Despite today's uptick, the stock has faced challenges over the

TickrTrends take: TransMedics Group Inc operates in the Healthcare sector and is currently trading at a significant discount to its GF Value estimate, which aligns with TickrTrends' Undervalued designation. The gap between the estimated fair value and current trading price suggests the stock may warrant attention from investors focused on valuation metrics, though such discrepancies can persist for various reasons including market sentiment, growth expectations, or risk assessments. Valuation-focused readers should monitor whether this gap narrows over time and what fundamental developments might influence the company's actual value relative to market pricing.

Read the full story at gurufocus.com →

Is TMDX undervalued? See TickrTrends' fair value analysis →